| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |